Minimum 10-year results of cementless total hip arthroplasty in patients with rheumatoid arthritis

Akihisa Haraguchi, Yasuharu Nakashima, Hisaaki Miyahara, Yukio Esaki, Ken Okazaki, Jun-Ichi Fukushi, Go Hirata, Satoshi Ikemura, Satoshi Kamura, Koji Sakuraba, Kenjiro Fujimura, Yukio Akasaki, Hisakata Yamada

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objectives: To retrospectively evaluate the long-term results of cementless total hip arthroplasty (THA) in patients with rheumatoid arthritis (RA) and postoperative patient mortality after THA. Methods: This study included 191 hips in 149 RA patients who underwent cementless THA between 1998 and 2005. Mean age at surgery was 54.2 years, and mean follow-up was 12.6 years. Implant and patient survivorships were determined using the Kaplan–Meier method, and the associated influencing factors were determined. Results: Implant survivals at 17 years were 99.5% for stems, 93.9% for cups, and 90.8% for liners. Among the liners used, THAs with highly cross-linked polyethylene showed better survivals compared with those with conventional polyethylene and alumina-bearing surface (93.4%, 90.9%, and 52.2%, respectively). A total of 64 deaths occurred; 45 patients died within 10 years and 19 patients died between 10 and 17 years. Malignancy (25.0%) was the leading cause of death, followed by pneumonia (20.8%) and sepsis (20.8%). The patient survival rate was 36.9% at 17 years after THA. Multivariate analysis exhibited that older age at operation and greater dose of concomitant corticosteroid resulted in shorter patient survivals. Conclusions: Cementless THA worked well in patients with RA. Mortality remained high among RA patients who needed THA.

Original languageEnglish
Pages (from-to)598-604
Number of pages7
JournalModern Rheumatology
Volume27
Issue number4
DOIs
Publication statusPublished - Jul 4 2017

Fingerprint

Arthroplasty
Hip
Rheumatoid Arthritis
Polyethylene
Survival
Survival Rate
Tacrine
Mortality
Aluminum Oxide
Cause of Death
Sepsis
Pneumonia
Adrenal Cortex Hormones
Multivariate Analysis

All Science Journal Classification (ASJC) codes

  • Rheumatology

Cite this

Minimum 10-year results of cementless total hip arthroplasty in patients with rheumatoid arthritis. / Haraguchi, Akihisa; Nakashima, Yasuharu; Miyahara, Hisaaki; Esaki, Yukio; Okazaki, Ken; Fukushi, Jun-Ichi; Hirata, Go; Ikemura, Satoshi; Kamura, Satoshi; Sakuraba, Koji; Fujimura, Kenjiro; Akasaki, Yukio; Yamada, Hisakata.

In: Modern Rheumatology, Vol. 27, No. 4, 04.07.2017, p. 598-604.

Research output: Contribution to journalArticle

Haraguchi, A, Nakashima, Y, Miyahara, H, Esaki, Y, Okazaki, K, Fukushi, J-I, Hirata, G, Ikemura, S, Kamura, S, Sakuraba, K, Fujimura, K, Akasaki, Y & Yamada, H 2017, 'Minimum 10-year results of cementless total hip arthroplasty in patients with rheumatoid arthritis', Modern Rheumatology, vol. 27, no. 4, pp. 598-604. https://doi.org/10.1080/14397595.2016.1256024
Haraguchi, Akihisa ; Nakashima, Yasuharu ; Miyahara, Hisaaki ; Esaki, Yukio ; Okazaki, Ken ; Fukushi, Jun-Ichi ; Hirata, Go ; Ikemura, Satoshi ; Kamura, Satoshi ; Sakuraba, Koji ; Fujimura, Kenjiro ; Akasaki, Yukio ; Yamada, Hisakata. / Minimum 10-year results of cementless total hip arthroplasty in patients with rheumatoid arthritis. In: Modern Rheumatology. 2017 ; Vol. 27, No. 4. pp. 598-604.
@article{59a4d2a67275489593005d44c9397083,
title = "Minimum 10-year results of cementless total hip arthroplasty in patients with rheumatoid arthritis",
abstract = "Objectives: To retrospectively evaluate the long-term results of cementless total hip arthroplasty (THA) in patients with rheumatoid arthritis (RA) and postoperative patient mortality after THA. Methods: This study included 191 hips in 149 RA patients who underwent cementless THA between 1998 and 2005. Mean age at surgery was 54.2 years, and mean follow-up was 12.6 years. Implant and patient survivorships were determined using the Kaplan–Meier method, and the associated influencing factors were determined. Results: Implant survivals at 17 years were 99.5{\%} for stems, 93.9{\%} for cups, and 90.8{\%} for liners. Among the liners used, THAs with highly cross-linked polyethylene showed better survivals compared with those with conventional polyethylene and alumina-bearing surface (93.4{\%}, 90.9{\%}, and 52.2{\%}, respectively). A total of 64 deaths occurred; 45 patients died within 10 years and 19 patients died between 10 and 17 years. Malignancy (25.0{\%}) was the leading cause of death, followed by pneumonia (20.8{\%}) and sepsis (20.8{\%}). The patient survival rate was 36.9{\%} at 17 years after THA. Multivariate analysis exhibited that older age at operation and greater dose of concomitant corticosteroid resulted in shorter patient survivals. Conclusions: Cementless THA worked well in patients with RA. Mortality remained high among RA patients who needed THA.",
author = "Akihisa Haraguchi and Yasuharu Nakashima and Hisaaki Miyahara and Yukio Esaki and Ken Okazaki and Jun-Ichi Fukushi and Go Hirata and Satoshi Ikemura and Satoshi Kamura and Koji Sakuraba and Kenjiro Fujimura and Yukio Akasaki and Hisakata Yamada",
year = "2017",
month = "7",
day = "4",
doi = "10.1080/14397595.2016.1256024",
language = "English",
volume = "27",
pages = "598--604",
journal = "Modern Rheumatology",
issn = "1439-7595",
publisher = "Springer Japan",
number = "4",

}

TY - JOUR

T1 - Minimum 10-year results of cementless total hip arthroplasty in patients with rheumatoid arthritis

AU - Haraguchi, Akihisa

AU - Nakashima, Yasuharu

AU - Miyahara, Hisaaki

AU - Esaki, Yukio

AU - Okazaki, Ken

AU - Fukushi, Jun-Ichi

AU - Hirata, Go

AU - Ikemura, Satoshi

AU - Kamura, Satoshi

AU - Sakuraba, Koji

AU - Fujimura, Kenjiro

AU - Akasaki, Yukio

AU - Yamada, Hisakata

PY - 2017/7/4

Y1 - 2017/7/4

N2 - Objectives: To retrospectively evaluate the long-term results of cementless total hip arthroplasty (THA) in patients with rheumatoid arthritis (RA) and postoperative patient mortality after THA. Methods: This study included 191 hips in 149 RA patients who underwent cementless THA between 1998 and 2005. Mean age at surgery was 54.2 years, and mean follow-up was 12.6 years. Implant and patient survivorships were determined using the Kaplan–Meier method, and the associated influencing factors were determined. Results: Implant survivals at 17 years were 99.5% for stems, 93.9% for cups, and 90.8% for liners. Among the liners used, THAs with highly cross-linked polyethylene showed better survivals compared with those with conventional polyethylene and alumina-bearing surface (93.4%, 90.9%, and 52.2%, respectively). A total of 64 deaths occurred; 45 patients died within 10 years and 19 patients died between 10 and 17 years. Malignancy (25.0%) was the leading cause of death, followed by pneumonia (20.8%) and sepsis (20.8%). The patient survival rate was 36.9% at 17 years after THA. Multivariate analysis exhibited that older age at operation and greater dose of concomitant corticosteroid resulted in shorter patient survivals. Conclusions: Cementless THA worked well in patients with RA. Mortality remained high among RA patients who needed THA.

AB - Objectives: To retrospectively evaluate the long-term results of cementless total hip arthroplasty (THA) in patients with rheumatoid arthritis (RA) and postoperative patient mortality after THA. Methods: This study included 191 hips in 149 RA patients who underwent cementless THA between 1998 and 2005. Mean age at surgery was 54.2 years, and mean follow-up was 12.6 years. Implant and patient survivorships were determined using the Kaplan–Meier method, and the associated influencing factors were determined. Results: Implant survivals at 17 years were 99.5% for stems, 93.9% for cups, and 90.8% for liners. Among the liners used, THAs with highly cross-linked polyethylene showed better survivals compared with those with conventional polyethylene and alumina-bearing surface (93.4%, 90.9%, and 52.2%, respectively). A total of 64 deaths occurred; 45 patients died within 10 years and 19 patients died between 10 and 17 years. Malignancy (25.0%) was the leading cause of death, followed by pneumonia (20.8%) and sepsis (20.8%). The patient survival rate was 36.9% at 17 years after THA. Multivariate analysis exhibited that older age at operation and greater dose of concomitant corticosteroid resulted in shorter patient survivals. Conclusions: Cementless THA worked well in patients with RA. Mortality remained high among RA patients who needed THA.

UR - http://www.scopus.com/inward/record.url?scp=85006100220&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006100220&partnerID=8YFLogxK

U2 - 10.1080/14397595.2016.1256024

DO - 10.1080/14397595.2016.1256024

M3 - Article

C2 - 27846746

AN - SCOPUS:85006100220

VL - 27

SP - 598

EP - 604

JO - Modern Rheumatology

JF - Modern Rheumatology

SN - 1439-7595

IS - 4

ER -